Cargando…
Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes
Interventional studies have demonstrated the impact of hyperglycemia on the development of vascular complications associated with type 2 diabetes, which underscores the importance of safely lowering glucose to as near-normal as possible. Among the current challenges to reducing the risk of vascular...
Autores principales: | Schnabel, Catherine A, Wintle, Matthew, Kolterman, Orville |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993968/ https://www.ncbi.nlm.nih.gov/pubmed/17319471 |
Ejemplares similares
-
Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
por: MacConell, Leigh, et al.
Publicado: (2015) -
Incretin Mimetics: Promising New Therapeutic Options in the Treatment of Type 2 Diabetes
por: Gleeson, Jeremy M., et al.
Publicado: (2005) -
The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes
por: Kinalska, Ida, et al.
Publicado: (2012) -
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
por: Hansen, Katrine B, et al.
Publicado: (2010) -
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
por: Gaebler, Julia A, et al.
Publicado: (2012)